2014 Distinguished Teaching Professor: Kenneth Skau, PhD
Kenneth Skau, PhD, a professor emeritus in the James L. Winkle College of Pharmacy has been selected as UCs 2014 recipient of the Distinguished Teaching Professor Award. He was honored at the All-University Faculty Awards celebration April 17, 2014.
Skau has devoted over three decades to teaching, with the majority of those years spent at UC.
In a nomination letter penned by Dean Neil MacKinnon, PhD, Skaus contributions to pharmacy education can be summed up in three words: commitment, competence and caringbut a fourth word also comes to mind: consistency, as evidenced by a 1985 graduates letter of support ("He teaches every lecture with zeal in a persistent manner, both challenging and inspiring students
) and reiterated by a 2009 graduate ("He truly exemplifies the spirit of this title as an enthusiastic advocate for scholarship and professional development
).
In addition to a commitment to teaching, Skau has made significant national contributions to pharmacy education. For example, he was the 2012-13 Donald C. Brodie Academic Scholar-in-Residence at the American Association of Colleges of Pharmacy (AACP) and focused his project on reflective writing and learning and its inclusion in the curriculum. Skau has the distinction of being a five-time recipient of the Rho Chi Faculty Excellence Award, is a member of UCs Academy of Fellows for Teaching and Learning and was part of the team which won the Innovations in Teaching Award from the AACP.
Beyond his teaching and scholarly pursuits, Skau is a tireless researcher with scores of published findings and is equally enthusiastic about clinical pharmacy.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.